1. Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV‐1 protease, reverse transcriptase, and integrase inhibitors. Issue 1 (17th March 2017) Authors: Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Vicenti, Ilaria; Zazzi, Maurizio Journal: Journal of clinical laboratory analysis Issue: Volume 32:Issue 1(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals. Issue 1 (January 2022) Authors: Boccuto, Adele; Dragoni, Filippo; Bergna, Annalisa; Ventura, Carla Della; Giammarino, Federica; Saladini, Francesco; Pezzati, Laura; Zehender, Gianguglielmo; Zazzi, Maurizio; Vicenti, Ilaria; Lai, Alessia Journal: Journal of infection Issue: Volume 84:Issue 1(2022) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. (June 2020) Authors: Vicenti, Ilaria; Dragoni, Filippo; Giannini, Alessia; Giammarino, Federica; Spinicci, Michele; Saladini, Francesco; Boccuto, Adele; Zazzi, Maurizio Journal: SLAS discovery Issue: Volume 25:Number 5(2020) Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dynamics of Total and Intact HIV-1 DNA in Virologically Suppressed Patients Switching to DTG-Based or ATV-Based Dual Therapy. (1st December 2022) Authors: Dragoni, Filippo; Rossetti, Barbara; Lombardi, Francesca; Spertilli Raffaelli, Chiara; Bartolini, Niccolò; Giammarino, Federica; Moschese, Davide; Di Giambenedetto, Simona; Fabbiani, Massimiliano; De Luca, Andrea; Vicenti, Ilaria; Zazzi, Maurizio; Saladini, Francesco Journal: Journal of acquired immune deficiency syndromes Issue: Volume 91:Number 4(2022) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study. Issue 8 (9th April 2022) Authors: Bavaro, Davide F.; De Vito, Andrea; Pasculli, Giuseppe; Bouba, Yagai; Magnasco, Laura; Pincino, Rachele; Saladini, Francesco; Lattanzio, Rossana; Corsini, Romina; Arima, Serena; Zazzi, Maurizio; Incardona, Francesca; Rossetti, Barbara; Bezenchek, Antonia; Vanni, Borghi; Di Biagio, Antonio Journal: Journal of medical virology Issue: Volume 94:Issue 8(2022) Page Start: 3890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study. (15th May 2018) Authors: Gagliardini, Roberta; Ciccullo, Arturo; Borghetti, Alberto; Maggiolo, Franco; Bartolozzi, Dario; Borghi, Vanni; Pecorari, Monica; Di Biagio, Antonio; Callegaro, Anna Paola; Bruzzone, Bianca; Saladini, Francesco; Paolucci, Stefania; Maserati, Renato; Zazzi, Maurizio; Di Giambenedetto, Simona; De L... Journal: Open forum infectious diseases Issue: Volume 5:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations. (24th September 2020) Authors: Saladini, Francesco; Giammarino, Federica; Hosseini, Behnaz A; Giannini, Alessia; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Shafer, Robert W; Zazzi, Maurizio Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 1(2021) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir. (17th August 2021) Authors: Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 12(2021) Page Start: 3310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients. (28th May 2020) Authors: Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Maggiolo, Franco; Vichi, Francesca; Corbelli, Giulio M; Galli, Andrea; Bigoloni, Alba; Poli, Andrea; Santoro, Maria M; Zazzi, Maurizio; Castagna, Antonella Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 9(2020) Page Start: 2547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects. (February 2022) Authors: Rusconi, Stefano; Saladini, Francesco; Bellocchi, Maria Concetta; Galli, Laura; Gagliardini, Roberta; Gazzola, Lidia; Francisci, Daniela; Vichi, Francesca; Focà, Emanuele; Zazzi, Maurizio; Santoro, Maria M.; Gabrieli, Arianna; Castagna, Antonella Journal: Pharmacological research Issue: Volume 176(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗